Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Fujisawa discloses vasopressin antagonists

Sep. 6, 1996

CPC-111 clinical trial results disclosed

Aug. 30, 1996

MHC-II and related molecules for treating septic shock

Aug. 30, 1996

Kirin Brewery synthesizes agents for arteriosclerosis

Aug. 30, 1996

Endothelin converting enzyme inhibitor revealed by Schering-Plough

Aug. 30, 1996

BTG and the New England Medical Center sign marketing agreement

Aug. 23, 1996

Santen reveals neutral endopeptidase inhibitors

Aug. 23, 1996

BMS-186716: Bristol-Myers Squibb's ACE/neutral endopeptidase inhibitor

Aug. 23, 1996

Carvedilol approved for CHF indication in Spanish market

Aug. 23, 1996

Adenosine reuptake inhibitors from Kyowa Hakko

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...